Vaneck Pharmaceutical ETF(PPH-Q)NASDAQ
Today's Change
Real-Time Last Update
After Hours Change
After Hours Last Update
Volume
Overview
Name
Fund Family
Underlying Index
Inception Date
Exchange
Description
The VanEck Vectors Pharmaceutical ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals. Expenses for PPH are capped contractually at 0.35% until at least February 1, 2018. Cap excludes certain expenses, such as interest.
Investment Information
Managed Assets, $K
Shares Outstanding, K
Asset Class
Sectors
ETFs - Healthcare
60-Month Beta
Net Asset Value
Management Fee
Most Recent Dividend
Last Dividend Date
Dividend Yield
Has Options
20-Day Average Volume
52-Week RangeLow price77.60-High price99.51
YTD Return %
1-Year %Chg
3-Year %Chg
5-Year %Chg
